MustGrow Biologics Corp.

Recent News

  • MustGrow Biologics Closes $7.1 Million Private Placement

    Saskatoon, Saskatchewan--(Newsfile Corp. - October 7, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce the closing of its previously-announced non-brokered private placement (the "Private Placement"). MustGrow has closed on an aggregate of 2,726,611 units for gross proceeds of C$7,089,189 effective October 6, 2021. Included in this sum, Ira Gluskin and Gluskin-related parties have invested C$1.0 million under the same terms and conditions.The Private Placement consists of units (each a "Unit") at...

    2021-10-07 7:00 AM EDT
  • MustGrow Biologics Upsizes Private Placement to $6.9 Million; Gluskin Invests $1 Million

    Saskatoon, Saskatchewan--(Newsfile Corp. - September 29, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce it has upsized its previously-announced C$2.0 million non-brokered private placement (the "Private Placement") to approximately 2.7 million units (each a "Unit") for gross proceeds of approximately C$6.9 million at a price per Unit of C$2.60. Ira Gluskin and Gluskin-related parties have subscribed to invest C$1.0 million in the Private Placement under the same terms and conditions.Each Unit...

    2021-09-29 7:02 AM EDT
  • MustGrow Biologics Arranges $2 Million Equity Private Placement

    Saskatoon, Saskatchewan--(Newsfile Corp. - September 13, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) ("MustGrow") is pleased to announce a non-brokered private placement (the "Private Placement") of approximately 770,000 units (each a "Unit") for gross proceeds of approximately C$2.0 million at a price per Unit of C$2.60. Each Unit shall consist of one common share of the Company and one-half of one common share purchase warrant (each a "Warrant"). Each full Warrant shall entitle the holder to...

    2021-09-13 7:02 AM EDT
  • MustGrow Biologics and Sumitomo Corporation Announce Exclusive Agreement

    Exclusive agreement with Sumitomo Corporation to evaluate MustGrow's technology to determine commercial potential.Sumitomo Corporation has option to acquire exclusive rights to MustGrow's technology for preplant soil fumigation, bioherbicide, postharvest and food preservation for potatoes, and bananas in North, Central, and South America.Sumitomo Corporation to fund and drive all field development, including toxicology, safety, efficacy, and regulatory work necessary for commercialization.MustGrow will complete its existing on-going field trials with other corporate collaborators.Saskatoon, Saskatchewan--(Newsfile Corp. - August 4, 2021) - MustGrow Biologics...

    2021-08-04 9:30 AM EDT
  • MustGrow Biologics Announces Positive Carnation Trials with Gowan

    Work completed under non-exclusive agreement with Gowan Group's biological division Ecoflora Agro in Colombia.MustGrow and Gowan reported control of Fusarium disease in carnation flower soil utilizing MustGrow's mustard-derived biopesticide.Soil treated with MustGrow's product showed resilient carnation yield and health, suggesting systemic protection. MustGrow's treatment outperformed the grower standard of steam sterilization.Saskatoon, Saskatchewan--(Newsfile Corp. - July 12, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce positive results from its non-exclusive floriculture trials (the...

    2021-07-12 7:02 AM EDT
  • MustGrow Achieves Control of Root-Rot Disease Aphanomyces in Greenhouse Trials

    Disease control of root-rot Aphanomyces in greenhouse testing across a range of economic rates.Plants treated with MustGrow's biopesticide were robust in plant and root system health.Aphanomyces is a soil-borne root-rot disease that destroys pulse crops (peas, lentils, and legumes).90% of Saskachewan pulse crop fields have shown Aphanomyces symptoms (2019).Saskatoon, Saskatchewan--(Newsfile Corp. - May 12, 2021) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce successful greenhouse efficacy results of its patented mustard-derived biopesticide on...

    2021-05-12 7:02 AM EDT
  • MustGrow Investor Webcast Today - Tuesday May 4th at 4:10pm ET

    Saskatoon, Saskatchewan--(Newsfile Corp. - May 4, 2021) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the "Company", "MustGrow"), an agriculture technology company focused on providing natural biological crop protection solutions, will discuss (via live webcast) recent achievements and upcoming catalysts. Live Webcast TODAY: Tuesday, May 4th at 4:10pm ET (Register/View Here)Please email questions to info@mustgrow.ca to be addressed following the presentation.Positive Soil Health and Environmental I

    2021-05-04 7:02 AM EDT
  • MustGrow Biologics and Univar Canada Ltd. Subsidiary NexusBioAg Announce Collaborative Field Trials Program in Canada

    Field Trials to commence for MustGrow's mustard-derived soil biopesticide in Canada for treatment of Clubroot disease in Canola and Aphanomyces disease in Pulse Crops. MustGrow's organic biopesticide is plant-based, harnessing the mustard seed's natural defense mechanism to control diseases, insect pests, and weeds.Saskatoon, Saskatchewan--(Newsfile Corp. - April 29, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) ("MustGrow") and Univar Canada Ltd.'s NexusBioAg ("NexusBioAg"), a division of Univar Solutions Inc., are pleased to announce a collaborative field trial...

    2021-04-29 7:02 AM EDT